Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a swiss university hospital and a nationwide predictive model

Infection Control and Hospital Epidemiology

Volumn 34, Issue 2, 2013, Pages 133-143

  Stewardson, Andrew ^a   Fankhauser, Carolina ^a   De Angelis, Giulia ^b   Rohner, Peter ^a   Safran, Edith ^a   Schrenzel, Jacques ^a   Pittet, Didier ^a   Harbarth, Stephan ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISEASE SURVEILLANCE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HAZARD RATIO; HOSPITAL COST; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

AGED; BACTEREMIA; BETA-LACTAMASES; CONFIDENCE INTERVALS; COST OF ILLNESS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FORECASTING; HOSPITALS, UNIVERSITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SWITZERLAND;

EID: 84872202088     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/669086     Document Type: Article

References (39)

1. Livermore DM, Canton R, Gniadkowski M, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165-174.
2. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009;64(suppl 1):i3-i10.
3. Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-b-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-1262.
4. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum b-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and metaanalysis. J Antimicrob Chemother 2007;60:913-920.
5. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007; 55:254-259.
6. Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum b-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med 2005;165:1375-1380.
7. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010;50:1017-1021.
8. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561-566.
9. Brun-Buisson C, Roudot-Thoraval F, Girou E, Grenier-Sennelier C, Durand-Zaleski I. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis. Intensive Care Med 2003;29:1464-1471.
10. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008;6:751-763.
11. Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M. Application of multistate models in hospital epidemiology: advances and challenges. Biom J 2011;53:332-350.
12. Beyersmann J, Kneib T, Schumacher M, Gastmeier P. Nosocomial infection, length of stay, and time-dependent bias. Infect Control Hosp Epidemiol 2009;30:273-276.
13. Mauldin PD, Salgado CD, Hansen IS, Durup DT, Bosso JA. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrob Agents Chemother 2010;54: 109-115.
14. Barnett AG, Beyersmann J, Allignol A, Rosenthal VD, Graves N, Wolkewitz M. The time-dependent bias and its effect on extra length of stay due to nosocomial infection. Value Health 2011; 14:381-386.
15. De Angelis G, Allignol A, Murthy A, et al. Multistate modeling to estimate the excess length of stay associated with meticillinresistant Staphylococcus aureus colonisation and infection in surgical patients. J Hosp Infect 2011;78:86-91.
16. Lambert ML, Suetens C, Savey A, et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011;11:30-38.
17. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000;355:1864-1868.
18. Harbarth S, Rohner P, Auckenthaler R, Safran E, Sudre P, Pittet D. Impact and pattern of gram-negative bacteraemia during 6 y at a large university hospital. Scand J Infect Dis 1999;31:163-168.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
20. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-797.
21. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: Approved Standard M7-A7. Wayne, PA: CLSI, 2006.
22. Aalen O, Johansen S. An empirical transition matrix for nonhomogeneous Markov chains based on censored observations. Scand J Stat 1978;5:141-150.
23. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical models based on counting processes. New York: Springer, 1993. 24. Hopitaux universitaires de Geneve. Guide pratique de comptabilité analytique pour les hopitaux latins compatible avec REKOLE_. http://comptabilite-analytique.hug-ge.ch/_library/pdf/GUIDE_PRATIQUE_CAE.pdf. Published 2009. Accessed July 19, 2012.
24. Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004;25:1090-1096.
25. World Health Organization (WHO). International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: WHO, 2007.
26. Swiss Federal Office of Statistics. Classification Suisse des Interventions Chirurgicales (CHOP) version 11. http://www.bfs.admin.ch/bfs/portal/fr/index/infothek/nomenklaturen/blank/blank/chop/02.html#parsys_50214. Published 2008. Accessed July 19, 2012.
27. Club d'utilisateurs APDRG Suisse. APDRG Suisse website. http://www.apdrgsuisse.ch. Published 2004. Accessed July 14, 2012.
28. Kronenberg A, Hilty M, Mühlemann K. Temporal trends of Enterobacteriaceae with resistance to higher generation cephalosporines in Switzerland, 2004 to 2010. In: Program and Abstracts of the 21st European Congress of Clinical Microbiology and Infectious Diseases. May 7-10, 2011; Milan, Italy. Abstract P 657.
29. Swiss Federal Office of Statistics. Statistique des hopitaux 2010-tableaux standard. http://www.bfs.admin.ch/bfs/portal/fr/index/themen/14/03/01/data/01.html. Published 2012. Accessed April 26, 2012.
30. Department of Regional Affairs, Economy, and Health, State Council (Geneva). Suivi des prestations de santé a Geneve, Décembre 2011, No10. http://ge.ch/dares/les-couts-de-la-sante-a-geneve/couts_sante_aujourd_hui_geneve-899.html. Published 2011. Accessed April 26, 2012.
31. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(suppl 2):S82-S89.
32. da Silva GJ, Mendonca N. Association between antimicrobial resistance and virulence in Escherichia coli. Virulence 2012;3: 18-28.
33. Harbarth S, Ferriere K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002;137:1353-1359.
34. Tumbarello M, Spanu T, Di Bidino R, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-b-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010; 54:4085-4091.
35. de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of an-timicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011;66:398-407.
36. de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011;8:e1001104.
37. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-1171.
38. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600-1606.
39. Yang YS, Ku CH, Lin JC, et al. Impact of extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumonia on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect 2010;43:194-199